Nicholas Salgia

1.1k total citations
35 papers, 362 citations indexed

About

Nicholas Salgia is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Nicholas Salgia has authored 35 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Nicholas Salgia's work include Renal cell carcinoma treatment (19 papers), Cancer Genomics and Diagnostics (10 papers) and Renal and related cancers (8 papers). Nicholas Salgia is often cited by papers focused on Renal cell carcinoma treatment (19 papers), Cancer Genomics and Diagnostics (10 papers) and Renal and related cancers (8 papers). Nicholas Salgia collaborates with scholars based in United States, Brazil and Germany. Nicholas Salgia's co-authors include Sumanta K. Pal, Paulo Gustavo Bergerot, Nazlı Dizman, Joann Hsu, Jeffrey M. Trent, Lauren Reining, John D. Gillece, Sarah K. Highlander, Manuel Caitano Maia and Megan Folkerts and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Nicholas Salgia

30 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas Salgia United States 9 199 178 166 76 76 35 362
Tatsunori Kiriu Japan 13 199 1.0× 119 0.7× 186 1.1× 57 0.8× 44 0.6× 26 460
Jahan J. Mohiuddin United States 9 118 0.6× 84 0.5× 94 0.6× 29 0.4× 39 0.5× 21 268
Shiho Ishizuka Japan 7 194 1.0× 150 0.8× 75 0.5× 24 0.3× 26 0.3× 10 335
Wan Zamaniah Wan Ishak Malaysia 10 314 1.6× 80 0.4× 196 1.2× 39 0.5× 107 1.4× 26 506
Takayuki Shimamoto Japan 6 228 1.1× 79 0.4× 129 0.8× 21 0.3× 20 0.3× 8 293
Steven S. Evans United States 10 163 0.8× 61 0.3× 62 0.4× 59 0.8× 113 1.5× 21 343
Fang Jingyuan China 7 63 0.3× 146 0.8× 84 0.5× 53 0.7× 85 1.1× 11 279
Vishal Navani Canada 11 205 1.0× 87 0.5× 172 1.0× 49 0.6× 34 0.4× 38 338
Hideki Takakura Japan 10 140 0.7× 126 0.7× 86 0.5× 71 0.9× 87 1.1× 20 386
Antoine Desîlets Canada 8 172 0.9× 135 0.8× 38 0.2× 20 0.3× 27 0.4× 30 278

Countries citing papers authored by Nicholas Salgia

Since Specialization
Citations

This map shows the geographic impact of Nicholas Salgia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Salgia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Salgia more than expected).

Fields of papers citing papers by Nicholas Salgia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Salgia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Salgia. The network helps show where Nicholas Salgia may publish in the future.

Co-authorship network of co-authors of Nicholas Salgia

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Salgia. A scholar is included among the top collaborators of Nicholas Salgia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Salgia. Nicholas Salgia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chawla, Neal Shiv, Nicholas Salgia, Ameish Govindarajan, et al.. (2025). Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung Carcinoma. JCO Precision Oncology. 9(9). e2400947–e2400947.
2.
Salgia, Nicholas, Yu Fujiwara, Bo Xu, et al.. (2025). Biological and Clinical Insight into the Prevention and Management of Metastatic Renal Cell Carcinoma with a Sarcomatoid Component. European Urology Focus. 11(3). 421–424.
3.
Salgia, Nicholas, Lin Wang, Kristopher Attwood, et al.. (2024). Stratification of Patients with Renal Cell Carcinoma by the Abundance of Sarcomatoid Features Reveals Differences in Survival and the Underlying Pathobiology. European Urology Oncology. 7(5). 973–977. 3 indexed citations
4.
Battle, Dena, Nicholas Salgia, Zeynep Büşra Zengin, et al.. (2024). Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy. Nutrients. 16(11). 1630–1630. 1 indexed citations
5.
Salgia, Nicholas, Zeynep Büşra Zengin, Sumanta K. Pal, & Nazlı Dizman. (2024). Renal Cell Carcinoma of Variant Histology: New Biologic Understanding Leads to Therapeutic Advances. American Society of Clinical Oncology Educational Book. 44(3). e438642–e438642. 4 indexed citations
6.
Bergerot, Cristiane Decat, Errol J. Philip, Ameish Govindarajan, et al.. (2023). Changes in Perception of Cure Among Patients With Genitourinary Cancers Initiating Immune Checkpoint Inhibitors: A Longitudinal Study. Clinical Genitourinary Cancer. 21(6). 626–630.e3. 1 indexed citations
7.
Govindarajan, Ameish, Nicholas Salgia, Haiqing Li, et al.. (2023). Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles. Frontiers in Immunology. 14. 1182581–1182581. 6 indexed citations
8.
Muddasani, Ramya, Ameish Govindarajan, Sabrina Salgia, et al.. (2022). Prolonging utilization of systemic therapy in oligoprogressive metastatic renal cell carcinoma using stereotactic body radiation therapy.. Journal of Clinical Oncology. 40(6_suppl). 336–336. 3 indexed citations
9.
Zengin, Zeynep Büşra, Caroline Weipert, Nicholas Salgia, et al.. (2021). Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic Renal Cell Carcinoma. Clinical Cancer Research. 27(17). 4807–4813. 18 indexed citations
10.
Zengin, Zeynep Büşra, Alex Chehrazi‐Raffle, Nicholas Salgia, et al.. (2021). Targeted therapies: Expanding the role of FGFR3 inhibition in urothelial carcinoma. Urologic Oncology Seminars and Original Investigations. 40(2). 25–36. 16 indexed citations
11.
Chehrazi‐Raffle, Alex, Luís Meza, Marice Alcantara, et al.. (2021). Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 9(3). e002009–e002009. 28 indexed citations
12.
Bergerot, Cristiane Decat, Errol J. Philip, Paulo Gustavo Bergerot, et al.. (2020). Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance status. Cancer. 127(3). 354–358. 22 indexed citations
13.
Zengin, Zeynep Büşra, Nicholas Salgia, Alex Chehrazi‐Raffle, et al.. (2020). Immune Related Adverse Events. The Cancer Journal. 26(5). 432–440. 3 indexed citations
14.
Zengin, Zeynep Büşra, Caroline Weipert, Joann Hsu, et al.. (2020). 701O Assessment of circulating cell-free tumor DNA (ctDNA) in 847 patients (pts) with metastatic renal cell carcinoma (mRCC) and concordance with tissue-based testing. Annals of Oncology. 31. S553–S554. 1 indexed citations
15.
Dizman, Nazlı, Nicholas Salgia, Paulo Gustavo Bergerot, et al.. (2020). Race/Ethnicity and Survival in Metastatic Renal Cell Carcinoma: Outcomes for Patients Receiving First Line Targeted Therapies. 4(3). 159–166. 1 indexed citations
16.
Salgia, Nicholas, Paulo Gustavo Bergerot, Manuel Caitano Maia, et al.. (2020). Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti–PD-1 Immune Checkpoint Inhibitors. European Urology. 78(4). 498–502. 148 indexed citations
17.
Meng, Wilson S., et al.. (2020). A drug delivery perspective on intratumoral-immunotherapy in renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 39(6). 338–345. 3 indexed citations
18.
Salgia, Nicholas, et al.. (2019). The Changing Landscape of Management of Metastatic Renal Cell Carcinoma: Current Treatment Options and Future Directions. Current Treatment Options in Oncology. 20(5). 41–41. 22 indexed citations
19.
Salgia, Nicholas, Sumanta K. Pal, Vincent Chung, et al.. (2019). Activity of RX-3117, an oral antimetabolite nucleoside, in subjects with advanced urothelial cancer: Preliminary results of a phase IIa study.. Journal of Clinical Oncology. 37(7_suppl). 455–455.
20.
Stack, Melinda E., Nicholas Salgia, & Wickii T. Vigneswaran. (2015). Successful Primary Repair of a Colopericardial Fistula: A Late Complication of Esophageal Replacement. The Annals of Thoracic Surgery. 100(4). 1459–1461. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatsunori Kiriu Breakdown of academic impact, for papers by Jahan J. Mohiuddin Breakdown of academic impact, for papers by Shiho Ishizuka Breakdown of academic impact, for papers by Wan Zamaniah Wan Ishak Breakdown of academic impact, for papers by Takayuki Shimamoto Breakdown of academic impact, for papers by Steven S. Evans Breakdown of academic impact, for papers by Fang Jingyuan Breakdown of academic impact, for papers by Vishal Navani Breakdown of academic impact, for papers by Hideki Takakura Breakdown of academic impact, for papers by Antoine Desîlets
Rankless by CCL
2026